DOPAMINE IS A PHYSIOLOGICAL REGULATOR OF THYROTROPIN (TSH) SECRETION IN NORMAL MAN

被引:146
作者
SCANLON, MF
WEIGHTMAN, DR
SHALE, DJ
MORA, B
HEATH, M
SNOW, MH
LEWIS, M
HALL, R
机构
[1] Endocrine Unit, Department of Medicine, Royal Victoria Infirmary, Newcastle Upon Tyne
关键词
D O I
10.1111/j.1365-2265.1979.tb03028.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Using a sensitive and precise radioimmunoassay for human TSH we have demonstrated significant elevations in serum TSH levels in euthyroid volunteers following administration of the dopamine receptor blocking drug metoclopramide when compared with placebo. The degree of TSH response is significantly greater in females than in males and is sustained over a 3‐hour period after a single oral 10 mg dose of metoclopramide. The degree of TSH release after metoclopramide is inversely related to the basal TSH level suggesting that dopamine is a determinant of low daytime TSH levels and is thus implicated in the circadian rhythm of TSH secretion. Pretreatment with 10 mg of metoclopramide orally, one hour before TRH administration leads to significant enhancement of the TSH response to TRH. Our findings provide further evidence for the physiological inhibitory role of dopamine in the control of TSH secretion in normal man. The possible mode of action of dopamine and the clinical implications of this neuroregulatory pathway are discussed. Copyright © 1979, Wiley Blackwell. All rights reserved
引用
收藏
页码:7 / 15
页数:9
相关论文
共 32 条
[11]  
GARCIACENTENERA JA, 1977, 11TH ACT END C LAUS
[12]   RADIOIMMUNOSSAY OF HUMAN SERUM THYROTROPHIN [J].
HALL, R ;
AMOS, J ;
ORMSTON, BJ .
BRITISH MEDICAL JOURNAL, 1971, 1 (5749) :582-&
[13]   INCREASED PROLACTIN AND THYROTROPIN SECRETION FOLLOWING ORAL METOCLOPRAMIDE - DOSE-RESPONSE RELATIONSHIPS [J].
HEALY, DL ;
BURGER, HG .
CLINICAL ENDOCRINOLOGY, 1977, 7 (03) :195-201
[14]   2 POOLS OF PITUITARY GONADOTROPIN - REGULATION DURING MENSTRUAL-CYCLE [J].
HOFF, JD ;
LASLEY, BL ;
WANG, CF ;
YEN, SSC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 44 (02) :302-312
[15]   PROLACTIN SECRETION BY METOCLOPRAMIDE IN MAN [J].
JUDD, SJ ;
LAZARUS, L ;
SMYTHE, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 43 (02) :313-317
[16]   EARLY EFFECTS OF STILBESTROL ON GROWTH-HORMONE AND PROLACTIN SECRETION AND ON PITUITARY MITOTIC-ACTIVITY IN MALE RAT [J].
LLOYD, HM ;
MEARES, JD ;
JACOBI, J .
JOURNAL OF ENDOCRINOLOGY, 1973, 58 (02) :227-231
[17]   INHIBITION OF THYROTROPIN AND PROLACTIN SECRETIONS IN PRIMARY HYPOTHYROIDISM BY 2-BR-ALPHA-ERGOCRYPTINE [J].
MIYAI, K ;
ONISHI, T ;
HOSOKAWA, M ;
ISHIBASHI, K ;
KUMAHARA, Y .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1974, 39 (02) :391-394
[18]   TSH, FSH AND PROLACTIN RESPONSES TO CONTINUOUS INFUSIONS OF TRH AND EFFECTS OF ESTROGEN ADMINISTRATION IN NORMAL MALES [J].
MORTIMER, CH ;
BESSER, GM ;
GOLDIE, DJ ;
HOOK, J ;
MCNEILLY, AS .
CLINICAL ENDOCRINOLOGY, 1974, 3 (02) :97-103
[19]   PROLACTIN RESPONSE TO CHLORPROMAZINE AND THYROTROPIN-RELEASING-HORMONE IN HYPERTHYROIDISM [J].
ONISHI, T ;
MIYAI, K ;
IZUMI, K ;
NAKANISHI, H ;
KUMAHARA, Y .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 40 (01) :30-32
[20]   EFFECT OF METOCLOPRAMIDE ON TURNOVER OF BRAIN DOPAMINE NORADRENALINE AND 5-HYDROXYTRYPTAMINE [J].
PERINGER, E ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (06) :442-444